Recently, the IL-20 subfamily of cytokines has garnered attention in cancer research due to its ability to influence host immune responses, modulate the activities of cells and molecules in the TME, and directly affect various premalignant and malignant tumors [12]. This evidence concerns the gene IL20 and cancer.